European multi-asset manager Candriam celebrated World Cancer Day (4 February) by unveiling an Oncology Impact fund, aimed at combating cancer.
The fund will invest in listed companies that are at the forefront of developing products and services targeting cancer – from diagnosis to treatment.
While scientific advances in battling cancer are progressing, the outlook for some patients is still very poor, as the illness is the second leading cause of death, globally, with 40% of men and women worldwide being diagnosed at some point in their lives.
The fund supports the development of a wide range of therapies in order to identify breakthrough innovations and slash the predicted rise of cancer deaths, which is set to hit 13 million people by 2030 – up 60% from the current eight million.
Candriam came out with this strategy to “give investors the opportunity to put their money into a fund which has a direct positive social impact”.
Additionally, the firm has pledged 10% of the management fees to go towards cancer research across European institutes.
Nordea Asset Management is expanding its fixed income ESG range with Nordea 1 – Emerging Stars Bond Fund, bolstering its existing Stars range.
The firm highlighted the traction ESG fixed income funds are gaining, especially among emerging markets investors, and decided to roll out one of its own.
The solution allows investors to keep investing in emerging markets but with an added ESG integration.
Therefore, investors would still benefit from the “risk-adjusted returns” in both medium and long term and, at the same time, push ESG issues in the emerging markets landscape, Nordea said.
The asset management group revealed two ETFs to allow investors to gain exposure to future trends.
The first ETF, Xtrackers Future Mobility Ucits, is designed to gain exposure to companies likely to benefit from emerging trends in mobility; such as the switch to electric and hybrid vehicles and electric and lithium batteries.
The second, called Xtrackers Artificial Intelligence and Big Data Ucits ETF, aims to provide access to companies likely to experience growth in technological developments; ranging from cloud computing, image recognition, chatbots and speech recognition.
Companies that own patents that are likely to create future technological trends on a global scale are also included in both ETFs.
The focus will be on up to 100 companies seen as “the winners of tomorrow”, considering the rapid technological advancements in both fields.
Both solutions use direct, physical replication and have annual all-in fees of 0.35%.